Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-21

FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves the original ANDA for rosuvastatin calcium from Ascend Laboratories, LLC, enabling the generic rosuvastatin calcium product to reach the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

ORIG AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)